References
  1. Davies G, Paton JY, Beaton SJ, et al. Children admitted with acute wheeze/asthma during November 1998-2005: a national UK audit. Arch Dis Child 2008; 93: 952–8
  2. Bloom CI, Nissen F, Douglas IJ, et al. Exacerbation risk and characterisation of the UK’s asthma population from infants to old age. Thorax 2018; 73: 313–20
  3. Brand PLP, Baraldi E, Bisgaard H, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32: 1096–110
  4. Makrinioti H, Klaber R, Watson M. Around the world: preschool wheeze. Lancet Respir Med. 2017; 5: 688-689
  5. Bush A, Pavord ID. ’We can’t diagnose asthma until <insert arbitrary age>’. Arch Dis Child. 2018; 103: 729-731
  6. Pavord ID, Beasley R, Agusti A, Anderson GP, Bel E, Brusselle G, et al. After asthma – redefining airways diseases. A Lancet commission. Lancet 2018; 391: 350-400
  7. Agusti A, Bel E, Thomas M, Vogelmeier C, Brusselle G, Holgate S, pet al. Treatable traits: toward precision medicine of chronic airway diseases. Eur Respir J. 2016; 47: 410-9.
  8. Mallol J, García-Marcos L, Solé D, Brand P; EISL Study Group. International prevalence of recurrent wheezing during the first year of life: variability, treatment patterns and use of health resources. Thorax. 2010; 65: 1004-9.
  9. Saglani S, Malmstrom K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med. 2005; 171: 722-727.
  10. Cane RS, McKenzie SA. Parents’ interpretations of children’s respiratory symptoms on video. Arch Dis Child. 2001; 84: 31-34.
  11. Turner S, Custovic A, Ghazal P, Grigg J, Gore M, Henderson J, et al. Pulmonary epithelial barrier and immunological functions at birth and in early life - key determinants of the development of asthma?  A description of the protocol for the Breathing Together study. Wellcome Open Res 2018; 3: 60
  12. Levy ML, Godfrey S, Irving CS, Sheikh A, Hanekom W, Ambulatory Care Nurses, Bush A, Lachman P. Wheeze detection in infants and pre-school children: recordings versus assessment of physician and parent. J Asthma 2004; 41: 845-853
  13. Marchant JM, Masters IB, Taylor SM, Cox NC, Seymour GJ, Chang AB. Evaluation and outcome of young children with chronic cough. Chest. 2006; 129: 1132-41.
  14. Chang AB, Bush A, Grimwood K. Bronchiectasis in children. Lancet 2018; 392: 866-879
  15. Chang AB, Fortescue R, Grimwood K, Alexopoulou E, Bell B, Boyd J, Bush A, et al . Task Force report: European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis. Eur Respir J 2021; 58: 2002990
  16. Bush A. Persistent Bacterial Bronchitis: Time to Venture beyond the Umbrella. Front. Pediatr., https://doi.org/10.3389/fped.2017.00264
  17. Bush A. Diagnosis of asthma in children under five. Prim Care Respir J. 2007; 16: 7-15
  18. Thompson M, Vodicka TA, Blair PS, Buckley DI, Heneghan C, Hay AD; TARGET Programme Team. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013; 347: f7027.
  19. Guilbert TW, Morgan WJ, Zeiger RS, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006; 354: 1985-7
  20. Murray CS, Woodcock A, Langley SJ, Morris J, Custovic A; IFWIN study team. Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy INfants (IFWIN): double-blind, randomised, controlled study. Lancet. 2006; 368: 754-62.
  21. Bisgaard H, Hermansen MN, Loland L, Halkjaer LB, Buchvald F. Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med. 2006; 354: 1998-2005.
  22. O’Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW; START Investigators Group. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009; 179: 19-
  23. Kotaniemi-Syrjänen A, Klemola T, Koponen P, Jauhola O, Aito H, Malmström K, et al. Intermittent Tiotropium Bromide for Episodic Wheezing: A Randomized Trial. Pediatrics. 2022; 150: e2021055860.
  24. Saglani S, Bingham Y, Balfour-Lynn I, Goldring S, Gupta A, Banya W, Moreiras J, Fleming L, Bush A, Rosenthal M. Blood eosinophils in managing preschool wheeze: Lessons learnt from a proof-of-concept trial. Pediatr Allergy Immunol. 2022; 33: e13697
  25. Dimova-Yaneva D, Russell D, Main M, Brooker RJ, Helms PJ. Eosinophil activation and  cysteinyl leukotriene  production in infants with respiratory syncytial virus bronchiolitis. Clin Exp Allergy. 2004; 34: 555-8AJRCCM 207; 175: 323-9
  26. Robertson CF, Price D, Henry R, Mellis C, Glasgow N, Fitzgerald D, Lee AJ, Turner J, Sant M. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med. 2007; 175: 323-9.
  27. Bacharier LB, Phillips BR, Zeiger RS, et al; CARE Network. Episodic use of an inhaled corticosteroid or leukotriene receptor antagonist in preschool children with moderate-to-severe intermittent wheezing. J Allergy Clin Immunol 2008; 122: 1127-35
  28. Valovirta E, Boza ML, Robertson CF, et al. Intermittent or daily montelukast versus placebo for episodic asthma in children. Ann Allergy Asthm Immunol 2011; 106: 518-26
  29. Nwokoro C, Pandya H, Turner S, et al. Intermittent montelukast in children aged 10 months to 5 years with wheeze (WAIT trial): a multicentre, randomised, placebo-controlled trial. Lancet Respir Med 2014; 2: 796-803
  30. Benard B, Bastien V, Vinet B, Yang R, Krajinovic M, Ducharme FM. Neuropsychiatric adverse drug reactions in children initiated on montelukast in real-life practice. Eur Respir J. 2017; 50: 1700148.
  31. Jaffe A, Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol 2001; 31: 464-473.
  32. Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet 1996; 347: 1507-10
  33. Bisgaard H, Hermansen MN, Bønnelykke K, Stokholm J, Baty F, Skytt NL, Aniscenko J, Kebadze T, Johnston SL. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ 2010; 341: c4978
  34. Stokholm J, Chawes BL, Vissing NH, et al. Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years: a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2016; 4: 19-26
  35. Bacharier LB, Guilbert TW, Mauger DT, Boehmer S, Beigelman A, Fitzpatrick AM, Jackson DJ, et al. Early Administration of Azithromycin and Prevention of Severe Lower Respiratory Tract Illnesses in Preschool Children With a History of Such Illnesses: A Randomized Clinical Trial. .JAMA. 2015; 314: 2034-2044.
  36. Mandhane PJ, Paredes Zambrano de Silbernagel P, Aung YN, Williamson J, Lee BE, Spier S, Noseworthy M, Craig WR, Johnson DW. Treatment of preschool children presenting to the emergency department with wheeze with azithromycin: A placebo-controlled randomized trial. PLoS One. 2017; 12: e0182411.
  37. Doan T, Worden L, Hinterwirth A, Arzika AM, Maliki R, Abdou A, Zhong L, Chen C, Cook C, Lebas E, O’Brien KS, Oldenburg CE, Chow ED, Porco TC, Lipsitch M, Keenan JD, Lietman TM. Macrolide and Nonmacrolide Resistance with Mass Azithromycin Distribution. N Engl J Med. 2020; 383: 1941-1950.
  38. Wilson N, Sloper K, Silverman M. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch Dis Child. 1995; 72: 317-20.
  39. Ducharme FM, Lemire C, Noya FJ, et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. NEJM 2009; 360: 339-53
  40. Zeiger RS, Mauger D, Bacharier LB, et al; CARE Network of the National Heart, Lung, and Blood Institute. Daily or intermittent budesonide in preschool children with recurrent wheezing. N Engl J Med 2011; 365: 1990-2001
  41. Brand PL, Caudri D, Eber E, Gaillard EA, Garcia-Marcos L, Hedlin G, Henderson J, Kuehni CE, Merkus PF, Pedersen S, Valiulis A, Wennergren G, Bush A. Classification and pharmacological treatment of preschool wheezing: changes since 2008. Eur Respir J. 2014; 43: 1172-7.
  42. Oommen A, Lambert PC, Grigg J. Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: randomised controlled trial. Lancet. 2003; 362: 1433-8.
  43. Panickar J, Lakhanpaul M, Lambert PC, Kenia P, Stephenson T, Smyth A, Grigg J. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med. 2009; 360: 329-38.
  44. Castro-Rodriguez JA, Beckhaus AA, Forno E. Efficacy of oral corticosteroids in the treatment of acute wheezing episodes in asthmatic preschoolers: Systematic review with meta-analysis. Pediatr Pulmonol. 2016; 51: 868-76.
  45. Foster SJ, Cooper MN, Oosterhof O, Borland ML. Oral prednisolone in preschool children with virus-associated wheeze: a prospective, randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2018; 6: 97-106.
  46. Saglani S, Rosenthal M, Bush A. Should oral corticosteroids be prescribed for pre-school wheeze? Lancet Respir Med 2018; 6: e21
  47. Bush A, Saglani S. Medical Algorithm: Diagnosis and Treatment of Pre-school Asthma. Allergy. 2200; 75: 2711-2712
  48. Jochmann A, Artusio L, Robson K, Nagakumar P, Collins N, Fleming L, Bush A, Saglani S. Infection and inflammation in induced sputum from preschool children with chronic airways diseases. Pediatr Pulmonol. 2016; 51: 778-86
  49. Fitzpatrick AM, Jackson DJ, Mauger DT, Boehmer SJ, Phipatanakul W, Sheehan WJ; NIH/NHLBI AsthmaNet. Individualized therapy for persistent asthma in young children. J Allergy Clin Immunol. 2016; 138: 1608-1618
  50. Fleming L, Tsartsali L, Wilson N, Regamey N, Bush A. Sputum inflammatory phenotypes are not stable in children with asthma. Thorax. 2012; 67: 675-81.
  51. Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, et al. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. Eur Respir J.  2020; 55: 1900588.
  52. Hartl S, Breyer MK, Burghuber OC, Ofenheimer A, Schrott A, Urban MH, Agusti A, Studnicka M, Wouters EFM, Breyer-Kohansal R. Blood eosinophil count in the general population: typical values and potential confounders. Eur Respir J. 2020; 55: 1901874.
  53. Fitzpatrick AM, Grunwell JR, Cottrill KA, Mutic AD, Mauger DT. Blood Eosinophils for Prediction of Exacerbation in Preschool Children With Recurrent Wheezing. .J Allergy Clin Immunol Pract. 2023: S2213-2198(23)00123-X.
  54. Couillard S, Laugerud A, Jabeen M, Ramakrishnan S, Melhorn J, Hinks T, Pavord I. Derivation of a prototype asthma attack risk scale centred on blood eosinophils and exhaled nitric oxide. Thorax. 2022; 77: 199-202.
  55. Robinson PFM, Pattaroni C, Cook J, Gregory L, Alonso AM, Fleming LJ, Lloyd CM, Bush A, Marsland BJ, Saglani S. Lower airway microbiota associates with inflammatory phenotype in severe preschool wheeze. J Allergy Clin Immunol. 2019; 143: 1607-1610.
  56. Robinson PFM, Fontanella S, Ananth S, Martin Alonso A, Cook J, Kaya-de Vries D, Polo Silveira L, Gregory L, Lloyd C, Fleming L, Bush A, Custovic A, Saglani S. Recurrent Severe Preschool Wheeze: From Pre-Specified Diagnostic Labels to Underlying Endotypes. Am J Respir Crit Care Med. 2021; 204: 523-53
  57. Heaney LG, Busby J, Hanratty CE, Djukanovic R, Woodcock A, Walker SM, et al; investigators for the MRC Refractory Asthma Stratification Programme. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Lancet Respir Med. 2021; 9: 57-68.
  58. Makrinioti H, Bush A, Griffiths C. What are patient-reported outcomes and why they are important: improving studies of preschool wheeze
  59. Zeiger RS, Mellon M, Chipps B, et al. Test for respiratory and asthma control in kids (track): clinically meaningful changes in score. J Allergy Clin Immunol 2011; 128: 983–8.
  60. Seid M, Limbers CA, Driscoll KA, et al. Reliability, validity, and responsiveness of the pediatric quality of life inventory (PedsQL) generic core scales and asthma symptoms scale in vulnerable children with asthma. J Asthma 2010; 47: 170-7
  61. Varni JW, Burwinkle TM, Rapoff MA , et al. The PedsQL in pediatric asthma: reliability and validity of the pediatric quality of life inventory generic core scales and asthma module. J Behav Med 2004; 27: 297–318.
  62. Ducharme FM, Jensen ME, Mendelson MJ , et al. Asthma flare-up diary for young children to monitor the severity of exacerbations. J Allergy Clin Immunol 2016; 137: 744–9
  63. Jensen ME, Mendelson MJ, Desplats E, et al. Caregiver’s functional status during a young child’s asthma exacerbation: a validated instrument. J Allergy Clin Immunol 2016; 137: 782–8.
Table1 Examples of treatable traits in pre-school wheeze [based on reference 7]